Eisai Fights Back After Australia Rejects Alzheimer's Drug Leqembi

The Therapeutic Goods Administration appears to share similar safety concerns regarding Leqembi as those expressed by the European Medicines Agency when it rejected the drug in July.

Human Hands Holding Brain Anatomy And Missing A Piece, Of Jigsaw
Leqembi is for the treatment of early Alzheimer's disease (Shutterstock)

More from Product Reviews

More from Approvals